Natural Alternatives International, Inc. NAII
At closeNov 3, 2026, 4:03 PM EST
After hours · Nov 3, 4:03 PM ET
- YTD
- -70.39%
- 1 year
- -61.17%
- Market cap
- 6.64M
- Revenue (ttm)
- 113.80M
- Profit margin
- -6.34%
- EPS (ttm)
- -3.43
- Shares out
- 6.20M
- YTD return
- -70.39%
- 1-year return
- -61.17%
- Volume
- 5.10K
- Avg volume
- 42.58K
- Open
- 1.08
- Previous close
- 1.07
- Day's range
- 1.06 – 1.08
- 52-week range
- 1.06 – 4.96
- Beta
- 0.59
2Y -3.47 (-76.43%)
Key statistics
- Enterprise value
- 11.15M
- PEG ratio
- 0.00
- Price / sales
- 0.23
- Price / book
- 0.33
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 26.50%
- Free cash flow
- -3.50M
- Total cash
- 32.13M
- Total debt
- 16.48M
- Return on equity
- -8.42%
- Short % of float
- 0.17%
- 50-day average
- 4.44
- 200-day average
- 5.66
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -0.33 | — | — |
| Sep 27, 2024 | Jun 1, 2024 | 0.00 | -0.32 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -0.27 | — | — |
| Feb 13, 2024 | Dec 1, 2023 | 0.00 | -0.52 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -0.12 | — | — |
| Sep 21, 2023 | Jun 1, 2023 | 0.00 | 0.35 | — | — |
About Natural Alternatives International, Inc.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Country
- United States
- Website
- nai-online.com
News
Natural Alternatives International (NASDAQ:NAII) Shares Cross Below 200 Day Moving Average – What’s Next?
Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure Update: Natural Alternatives Intl Q4 Adj. EPS $(0.52) Up From $(1.20) YoY, Sales $34.508M Up From $33.866M YoY
Natural Alternatives Intl Q4 EPS $(2.23) Down From $(1.20) YoY, Sales $34.508M Up From $33.866M YoY
Natural Alternatives International Says Initiated A Comprehensive Review Process To Explore Strategic Alternatives; Initiated Consolidation Of Our USA Manufacturing Operations Into Our Vista, CA Facility
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
Head to Head Review: Natural Alternatives International (NASDAQ:NAII) vs. Unilever (NYSE:UL)
3 Microcaps for Your Watchlist
Natural Alternatives International (NASDAQ:NAII) Stock Crosses Below 200 Day Moving Average – Here’s What Happened
Top 3 Risk Off Stocks That May Rocket Higher In Q3
Your note
Sign in to keep a note on NAII — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DUNN ALAN G | Director | Stock Award(Grant) | Mar 7, 2024 | 83,211 |
| FORTIN MICHAEL E. | Chief Financial Officer | Stock Award(Grant) | Mar 7, 2024 | 57,404 |
| LEDOUX MARK A | Chief Executive Officer | Stock Award(Grant) | Mar 7, 2024 | 732,942 |
| MATHERLY LAURA KAY | Director | Stock Award(Grant) | Mar 7, 2024 | 26,000 |
| RAMANATHAN GURU P | Director | Stock Award(Grant) | Mar 7, 2024 | 22,000 |
| WOLF KENNETH EUGENE | President | Stock Award(Grant) | Mar 7, 2024 | 139,553 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dimensional Fund Advisors LP | 6.88% | 426,672 | 1.77M | Sep 29, 2024 |
| Caldwell Sutter Capital, Inc. | 6.69% | 414,475 | 1.72M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 5.18% | 320,856 | 1.33M | Sep 29, 2024 |
| Vanguard Group Inc | 3.92% | 243,062 | 1.01M | Sep 29, 2024 |
| Morgan Stanley | 2.74% | 170,091 | 705.88K | Sep 29, 2024 |
| Bridgeway Capital Management, Inc. | 2.03% | 126,064 | 523.16K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.62% | 162,521 | 674.46K | Sep 29, 2024 |
| DFA U.S. Small Cap Value Series | 2.41% | 149,173 | 619.07K | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 1.22% | 75,454 | 313.13K | Sep 29, 2024 |
| DFA U.S. Micro Cap Series | 1.09% | 67,637 | 280.69K | Jul 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.81% | 50,300 | 208.75K | Sep 29, 2024 |
| DFA U.S. Targeted Value Portfolio | 0.69% | 43,065 | 178.72K | Jul 30, 2024 |
